Connect with us

Cannabis News

New Jersey Lawmakers Approve Bill To Legalize Psilocybin Therapy

Published

on

New Jersey lawmakers have advanced a bill provide adults with regulated therapeutic access to psilocybin with appropriate health conditions, with the intention of continuing to work to enact it in the 2026 legislative session.

More than a year after the House Health Committee first took up and amended the legislation — sponsored by Reps. Herb Conaway (D), Clinton Calabrese (D) and Anthony Verrelli (D) — the panel met Monday, taking testimony and benefiting from it.

“We’re all broke in one way, shape or form,” Verrelli (D), one of the bill’s sponsors, said at Monday’s hearing. “This bill gives people another chance to heal and improve. And if they get better, it gives them an opportunity to improve their communities, their families and their lives in general, to break that cycle of trauma, whatever it looks like.”

The committee amended the legislation last year to match the Senate version. To the disappointment of the defenders, however, this meant removing provisions that would have more broadly legalized psilocybin for adult use.

The plan, which included the personal legislative provisions that were originally introduced in the same form as the one proposed by lawmakers in the 2024 session, has recently been released in amended versions. Those ingredients would make it legal for adults to “possess, possess, use, ingest, inhale, process, transport, deliver without consideration, or distribute without consideration” four grams or less of psilocybin.

The amended measures, however, would significantly expand legislation introduced in late 2020 to reduce penalties for possessing an ounce of psilocybin. That reform Governor Phil Murphy (D) signed it into law in 2021

Stacy Swanson, who testified on behalf of Veterans Exploring Treatment Solutions (VETS), emphasized at Monday’s hearing that “the invisible wounds of war don’t just affect the veteran, they affect the entire family.”

“This bill does not legalize recreational drugs,” he said. “It creates structured access that is clinically supervised, with the necessary integration and monitoring.”

In its modified version, The invoice It would charge the Department of Health (DOH) with regulating and licensing the manufacture, testing, transportation, delivery, sale and purchase of psilocybin. There would be five types of licenses: manufacturer, service center operator, testing lab, facilitator, and psilocybin worker.

The Psilocybin Advisory Committee would establish appropriate medical conditions for use, propose guidelines for psilocybin services and dosage, craft safety studies and informed consent practices, and oversee the education, training, and conduct of facilitators.

The stated goal would be to develop a long-term strategic plan for safe, accessible, and affordable access to psilocybin for those 21 and older.

Toward this end, a social equity program would include implementing grants to help low-income people cover the costs of psilocybin services. DOH would direct the implementation of programs for technical assistance, fee reduction and other support services.

Jesse McLaughlin, state advocacy director for Reason for Hope, said Monday hearing that psychedelic medicine represents “the next big step forward in psychiatry” and we need to prepare our healthcare system for it.

“Psilocybin therapy is time-intensive, labor-intensive and different from the way psychiatric care is delivered today,” he said.

To access psilocybin services under the bill, a patient with a qualifying condition would have to obtain a referral from a licensed health care professional. Services would also include mandatory preparation and integration sessions before and after psilocybin administration.

The Assembly bill is in the hands of the Appropriations Committee. The Friend the Senate has already cleared two panels in that chamber—Health, Human Services and Elderly Committee and Budget and Credit Committee.

A survey of New Jersey residents released last year bears this out A majority of state residents agree with making psilocybin available for therapeutic usealthough they were not specifically asked about the specific legislation.

The poll, by Stockton University’s William J. Hughes Center for Public Policy, found that 55 percent of respondents supported legalizing psilocybin for medical use under the supervision of a physician. Only 20% of respondents were against, and 24% were not sure. A percentage of respondents refused to answer the question.


It’s Marijuana Time tracking hundreds of cannabis, psychedelic and drug policy bills in state legislatures and Congress this year. Patreon supporters by pledging at least $25/month, you’ll get access to our interactive maps, charts, and audio calendars so you never miss a development.


Learn more about our marijuana bill tracking and become a Patreon supporter to gain access

In other New Jersey drug policy news, Voters earlier this month chose U.S. Rep. Mikie Sherrill (D-NJ) to be the state’s next governor.and now there’s a clearer path to the marijuana reform that consumers and advocates in the Garden State have long awaited: the option to grow it at home.

Meanwhile, as New Jersey’s first marijuana lounges opened this summerregulators shared information on where to find the sites and offered advice on the responsible use of cannabis in licensed businesses, including rock culture classics like “puff, puff, pass.”

New Jersey officials have also completed the curriculum for a no-cost marijuana training academy to help entrepreneurs interested in entering the cannabis industry.

Separately, in May, New Jersey Senate President Nick Scutari (D) introduced a bill that would recriminalize the purchase of marijuana from unlicensed sources-A last ditch effort to combat the illegal market and direct adults to licensed dealers.

In March, a former New Jersey Senate leader unsuccessfully ran for this year’s Democratic nomination for governor. “It’s time” to allow medical marijuana patients to grow their own cannabis plants for personal use. He also pledged to expand amnesty for people affected by the criminalization of marijuana, if elected, and supported the establishment of cannabis consumption halls.

The comments by Sweeney, the longest-serving Senate president in the state’s history, diverge from what the current governor has repeatedly said about home growing, arguing that the state’s adult marijuana market needs to mature more before allowing home growing.

That claim appears to be contradicted by dozens of small marijuana businesses and advocacy groups in New Jersey recently He asked Parliament to allow adults to grow their own cannabis.

user photo CostaPPR.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Become a patron on Patreon!

Cannabis News

Maximizing cannabis yields with intercanopy and subcanopy lighting

Published

on

By







Continue Reading

Cannabis News

Transportation Groups Warn Feds Of Marijuana Rescheduling’s ‘Consequences’ For Drug Testing Of Truck Drivers And Pilots

Published

on

By

A coalition of transportation and safety organizations said they have “serious safety concerns” about the Trump administration’s move to federally regulate marijuana.

Led by the American Trucking Association, the groups sent a letter to federal officials Monday asking them to take steps to ensure truck drivers, pilots, transit operators and other safety-sensitive workers continue to be tested for cannabis.

“If employers do not take the necessary steps to preserve the ability of security-sensitive transportation workers to test for marijuana, this change could have significant consequences for the safety of passengers and the entire transportation industry,” wrote Acting Attorney General Todd Blanche, Drug Enforcement Administration (DEA) Administrator Terrance Cole, Health and Human Services Secretary Robert F. Kennedy, and Transportation Secretary J.

The organizations said they understand that federal officials are being “urgently” reorganized under an executive order from President Donald Trump, that they are “deeply concerned that the current process does not adequately take into account agencies responsible for transportation safety or protecting the traveling public” and that they want the agencies to “work together.” ongoing cannabis redistricting hearings and rulemaking process to address these concerns.

In May, the Department of Transportation (DOT) issued new guidelines saying just that Truck drivers, airline pilots and other safety-sensitive workers still cannot use medical marijuana without penalty despite the Trump administration’s move to reschedule.

“Marijuana use is incompatible with safety-sensitive functions,” the department said.

Medical review officers (MROs) who receive drug test results indicating cannabis use cannot rule them out as negative for illegal substance use, even if an employee claims it was a result of state-licensed medical marijuana.

“Currently, there is no way for an MRO to verify that a laboratory-confirmed marijuana drug test result is positive when an employee claims the positive was caused by a state-licensed marijuana product,” the DOT said, explaining that after the reprogramming, medical marijuana dispensed under state law “does not” constitute a drug approved by the Food and Drug Administration (FDA).

The transportation groups said in the new letter that the DOT’s drug-testing program “is in accordance with the Department of Health and Human Services’ (HHS) Mandatory Guidelines for Federal Workplace Drug Testing Programs and HHS-certified laboratories.”

“While DOT has expressed its intention to continue testing marijuana, a commitment we greatly appreciate, it is unclear whether DOT will retain its ability to rely on HHS procedures and certifications after the rescheduling,” they wrote. “Without this alignment, DOT may retain the authority to conduct testing, but lack the scientific and procedural infrastructure to do so.”

“Practically, this would mean that truck and bus drivers, pilots, flight attendants, air traffic controllers, air mechanics, railroad workers, dispatchers and signal workers, transit operators and pipeline workers could continue to perform high-risk safety roles without a reliable means of verifying that they are not actively using marijuana. It relies on controlled substance testing to identify end use and prevent potentially impaired individuals from fulfilling their safety-related obligations. While the planning could create legal or regulatory loopholes, the regulated employer-based drug testing agency warned that the final rules should not jeopardize marijuana testing for safety-sensitive transportation workers.”

“Regardless of the broader policy goals of the review, the federal government should not move forward to preserve transportation drug testing programs and mitigate the risks of increased and unchecked deterioration of our roads, railroads, public transportation systems, pipelines, airspace, and maritime corridors,” the letter says.

The organizations specifically ask federal officials to:

  • Support long-term marijuana testing for all safety-sensitive transportation workers;
  • Confirm the authority of DOT-regulated employers to perform such tests;
  • Ensure HHS laboratory certification and testing guidelines remain available and aligned with DOT’s safety mission; and
  • Establish a coordinated federal strategy to address the transportation security implications of rescheduling.

“The public and the workers who keep our transportation system running safely deserve a process that ensures these safeguards are firmly in place before any final action is taken,” he said. the letter he says

Earlier this month, the House Appropriations Committee approved a provision to allow federal officials to continue requiring government employees and security-sensitive employees, such as truck drivers and airline pilots must be drug tested for marijuana, “regardless of any future change in legal status or schedule.”

This was followed by a press conference organized by prohibitionist groups and a drug-testing industry association, where both Republican lawmakers joined the proclamation. “Cut” to marijuana rescheduling by asserting that safety-sensitive transportation workers can still be punished for testing positive for THC.

Legislators and abolitionist activists argued that moving marijuana to Schedule III would lead to a 1986 executive order signed by President Ronald Reagan defining illegal drugs under the Controlled Substances Act (CSA) in relation to the use of cannabis by truck drivers and other airline employees.

Last October, Transportation Secretary Sean Duffy suggested that President Donald Trump was “putting pressure” on rescheduling cannabis.arguing that marijuana is “truly addictive” and that policy reform on the issue sends a “dangerous” message.

“At a time when the culture is encouraging and celebrating the use of marijuana, we’re not talking about risk,” Duffy said.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Continue Reading

Cannabis News

Experts say THC percentage is the wrong way to shop for cannabis

Published

on

By


Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media